Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Apyx Medical Corp (APYX)

Apyx Medical Corp (APYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Apyx Medical Corp 5115 Ulmerton Road Clearwater FL 33760 USA

www.apyxmedical.com P: 727-384-2323

Description:

Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States.

Key Statistics

Overview:

Market Capitalization, $K 48,848
Enterprise Value, $K 38,388
Shares Outstanding, K 34,644
Annual Sales, $ 52,350 K
Annual Net Income, $ -18,710 K
Last Quarter Sales, $ 14,660 K
Last Quarter Net Income, $ -9,610 K
EBIT, $ -17,270 K
EBITDA, $ -16,580 K
60-Month Beta 1.10
% of Insider Shareholders 13.10%
% of Institutional Shareholders 55.33%
Float, K 30,106
% Float 86.90%
Short Volume Ratio 0.29

Growth:

1-Year Return -58.79%
3-Year Return -85.31%
5-Year Return -75.46%
5-Year Revenue Growth 213.66%
5-Year Earnings Growth -82.76%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 03/21/24
Latest Earnings Date 05/09/24 [BMO]
Earnings Per Share ttm -0.53
EPS Growth vs. Prev Qtr -46.15%
EPS Growth vs. Prev Year -11.76%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

APYX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -54.90%
Return-on-Assets % -28.41%
Profit Margin % -35.74%
Debt/Equity 1.23
Price/Sales 0.94
Price/Cash Flow N/A
Price/Book 1.83
Book Value/Share 0.78
Interest Coverage -7.58
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar